Published July 7, 2025
The Capital Newsrooms checks in with Dr. Andrew Talal, a member of the state’s Hepatitis C Elimination Task Force, who provides an update on New York’s goal of eliminating the transmission of the virus by 2030. He discusses work being spearheaded by the University of Buffalo and recommendations for state policymakers.
Dr. Talal's company, Empath Medical Innovations, is actively supported across BEP – including the filing of provisional patent application, mentorship, Accelerator funding, participation in the Cultivator early-stage startup program and HIMSS I-Corps.